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Abstract 
Magnetic nanoparticles and ultrasound contrast agents have both been used as vehicles for 
therapeutic delivery. More recently, magnetic microbubbles have been developed as a new 
theranostic agent which combines the advantages of the individual carriers and overcomes 
many of their limitations. In a previous study of gene delivery using magnetic microbubbles, it 
was found that a combination of magnetic liquid droplets and non-magnetic phospholipid 
microbubbles produced higher transfection rates than magnetic microbubbles. The reasons 
for this were not fully understood, however. The aim of this study was to investigate the 
hypothesis that conjugation between the droplets and the microbubbles occurred. A com-
bination of optical and fluorescence microscopy and ultrasound imaging studies in a flow 
phantom were performed. No interaction between magnetic droplets and microbubbles was 
observed under optical microscopy but the results from the fluorescence and acoustic im-
aging indicated that magnetic droplets and microbubbles do indeed combine to form a new 
magnetically and acoustically responsive particle. Theoretical calculations indicate that the 
driving force of the interaction is the relative surface energy and thus thermodynamic stability 
of the microbubbles and the droplets. The new particles were resistant to centrifugation, of 
comparable echogenicity to conventional ultrasound contrast agents and could be retained by 
a magnetic field (0.2T) in a flow phantom at centre line velocities of ~6 cm s-1 and shear rates 
of ~60 s -1. 
Key words: Microbubbles, magnetic nanoparticles, therapeutic ultrasound 
1. Introduction 
1.1. Background 
A large body of research in recent years has 
shown the considerable potential of both microbub-
bles and magnetic nanoparticles individually as ef-
fective theranostic agents (1-3). In addition to 
providing contrast enhancement in ultrasound imag-
ing, coated microbubbles have been widely shown to 
improve cellular uptake of therapeutic material (4). 
This effect, termed sonoporation, reversibly enhances 
the permeability of the surfaces of nearby cells and is 
thought to be produced by the oscillations of mi-
crobubbles under ultrasound excitation (5). Close 
proximity between the microbubbles and target cells 
is required for therapeutic effects to be realised 
without unwanted damage and at moderate ultra-
sound intensities (6). Similarly, adequate numbers of 
microbubbles are required at the target site, but in-
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creasing microbubble concentration can pose an in-
creased risk of embolism and shield target tissue from 
ultrasound exposure (7). Efficient bio-chemical tar-
geting of microbubbles still represents a considerable 
challenge in vivo and surface architectures that max-
imise ligand exposure also boost presentation of im-
munogenic compounds that leads to early particle 
clearance or a hypersensitivity response (2, 7). 
Magnetic particles, on the micro and nano scale, 
have been investigated for the delivery of therapeutic 
agents for decades (8-10). Magnetic nanoparticles 
have also been used more recently for gene delivery. 
The association of genes with magnetic nanoparticles 
for magnetically guided nucleic acid delivery has 
been termed “magnetofection” (11). Magnetic nano-
particles can be used for targeting as they can be ex-
ternally controlled by a magnetic field and can also be 
visualised by Magnetic Resonance Imaging (MRI). 
However, the small size of the magnetic nanoparticles 
means they cannot be retained as individual particles 
under physiologically relevant flow conditions (12). A 
combination of these delivery methods in the form of 
magnetic microbubbles has the potential to overcome 
many of these limitations. Magnetic microbubbles can 
be visualised using ultrasound imaging, localised 
using an externally applied magnetic field and thus 
exploit the combined effects of magnetofection and 
sonoporation for therapeutic delivery.  
In 2000, Soetanto et al. electrostatically attached 
magnetic microparticles, coated with charged stea-
rates, via a calcium ion to microbubbles also formed 
with charged stearates (13, 14). According to the liter-
ature however, the large size of the microparticles and 
the effect conditions in vivo would have upon the 
electrostatic interactions were causes for concern. 
Magnetic microbubble formulations have since been 
developed for dual purpose ultrasound and MRI 
contrast agents and as drug delivery vehicles (15-18). 
In the case of the latter, Stride et al. (19) published a 
study in which magnetic microbubbles were used for 
gene delivery to Chinese hamster ovary cells. Differ-
ent formulations of magnetic microbubbles, 
non-magnetic microbubbles and magnetic liquid 
droplets were co-injected with naked plasmid DNA 
encoding for luciferase and the cells exposed to a 
magnetic field, ultrasound or both. In addition, the 
experiments were performed with the cells on either 
the upper or lower surface of the culture plate so that 
in the case of the former, buoyant bubbles would be in 
contact with the cells. In the case of the latter, how-
ever, they would be separated by a distance of 2 mm 
unless they were magnetically-responsive in which 
case they would be translated downwards in the 
presence of a magnet. It was found that the highest 
rates of transfection were achieved with simultaneous 
exposure to ultrasound and a magnetic field, with the 
cells on the lower surface and with 2 formulations 
(Figure 1): magnetic microbubbles (consisting of a gas 
core coated in an oil suspension of magnetic nano-
particles and stabilised by a phospholipid coating) 
and secondly non-magnetic microbubbles mixed with 
magnetic droplets (droplets of ferrofluid, stabilised by 
a phospholipid coating). This combination of mag-
netic droplets and non-magnetic microbubbles pro-
duced a higher degree of transfection than magnetic 
microbubbles (19). 
 
Figure 1: Transfection enhancement as determined from Luciferase expression by Chinese hamster ovary cells 24 h after exposure to 
naked plasmid DNA with: an applied magnetic field (MF) and/or ultrasound (US) (10 s of pulsed insonation at 1 MHz, 1 MPa peak-to-peak, 
10 kHz PRF) in the presence of non-magnetic bubbles (A) and/or magnetic liquid droplets (B) or magnetic microbubbles (Ci or Cii) with 
cells located on either the upper or lower surface of the cell culture chamber. Full experimental details may be found in [19]. Reproduced 
with permission from Elsevier. 
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1.2. Motivation and Objectives 
The reason why magnetic droplets mixed with 
microbubbles produced transfection was not fully 
understood, since it was expected that the drop-
let/microbubble mixture would produce similar re-
sults to droplets alone. Two hypotheses were pro-
posed: first that magnetic droplets were somehow 
coupled to microbubbles, although this was not evi-
dent under microscopic examination; or second that 
magnetic droplets had a sensitising effect upon the 
cells which amplified the effect of the microbubbles, 
overcoming the fact that they were not in close 
proximity to the cells (19). The aim of this study was 
to investigate these observations further and in par-
ticular to test the first hypothesis through examina-
tion of microbubble/droplet mixtures under optical 
and fluorescence microscopy and to examine their 
response to a combination of magnetic and ultra-
sound fields in a flow phantom to determine their 
ability to be imaged and retained under physiologi-
cally relevant conditions.  
2. Materials and Methods 
L-α-phosphatidylcholine and petroleum ether, 
pure (boiling range 180-280 °C) were purchased from 
Sigma Aldrich, Poole, UK. The ferrofluid suspension 
of 10 nm spherical magnetite nanoparticles in isopar-
affin (10% volume fraction) was purchased from Liq-
uids Research, Bangor, UK. The fluorophore BODIPY 
C10 was synthesised and kindly provided by the 
Chemistry Department, Imperial College London (20).  
2.1. Bubble preparation 
Non-magnetic microbubbles were prepared with 
L-α-phosphatidylcholine based upon the technique of 
Stride et al. [19]. 15 mg of the lipid powder was 
weighed into a vial rinsed with surgical spirit (BP 
Unichem, Surrey, UK). Deionised water (15 ml) was 
then added to the vial and the mixture sonicated for 
30 s with an ultrasonic cell disruptor (XL 2000, probe 
diameter 3 mm, Misonix Inc. Farmingdale, NY, USA). 
This solution was then vigorously shaken for an ad-
ditional 30 s. Magnetic microbubbles were prepared 
via the same method but 15 µl of the magnetic nano-
particle suspension was added to the lipid mixture 
after sonication. This was followed by an additional 
30 s of sonication and 30 s of manual shaking. Mag-
netic droplets were also prepared by a similar method 
but omitting manual shaking and during sonication 
care was taken to keep the probe tip well below the 
liquid surface to avoid entraining gas.  
Fluorescent formulations, magnetic and 
non-magnetic, were prepared via the following 
method. L-α-phosphatidylcholine dissolved in chlo-
roform (80 µl) and BODIPY C10 dissolved in chloro-
form (2 µl) were added to a glass vial and agitated 
using a vortex mixer for 30s (VWR digital vortex 
mixer running at 1500 rpm). This mixture was then 
dried with a constant nitrogen flow for 30 min. De-
ionised water (2 ml) was added followed by bath 
sonication (Crest Ultrasonics, Model No 950HTAG, 
Trenton, NJ, USA) at room temperature for 1 min. The 
solution was transferred to a plastic vial followed by 
isoparaffin (2 µl), with or without magnetic nanopar-
ticles, and the solution was probe sonicated and then 
shaken manually, each for 30s.  
The phospholipid microbubbles were mixed 
with the droplets (magnetic and non-magnetic) as 
follows: magnetic droplets (0.5 ml) were extracted 
with a 1 ml syringe followed by microbubbles (0.5 ml) 
and the mixture was inverted 3 times to allow the 
bubbles to pass through the magnetic droplet mixture. 
Three batches of each type of particle suspension were 
prepared for the experiments. 
2.2. Optical Microscopy 
The microbubbles, droplets and microbub-
ble-droplet mixture were examined using optical mi-
croscopy to determine the particle size distribution 
and concentration. 10 µl was removed from the sam-
ple solution and examined on a haemocytometer 
(Bright-Line, Hausser Scientific, Horsham, PA, USA). 
Images were obtained at 400x magnification with a 
standard light microscope (Bresser Optical Micro-
scope No 0510119). Samples were taken from each of 
the 3 batches and 30 images were taken from each 
sample. The bubble size distribution and concentra-
tion were then obtained using purpose written image 
analysis software in MatLab (2010B, The MathWorks, 
Natick, MA, USA) (21). All experiments were per-
formed at the ambient temperature in accordance 
with the conditions under which bubbles were pre-
pared in [19]. 
2.3. Fluorescence experiments 
Fluorescence microscopy was used to investigate 
the interaction between magnetic droplets and mi-
crobubbles. Images were obtained with an excitation 
wavelength of 490 nm and an absorption wavelength 
of 525 nm (Leica DMI6000B, FITC filter set). The 
manufacturer supplied software (Leica AF7000) was 
used to analyse the images. To analyse the 
non-magnetic droplets, images were acquired with a 
Nikon Eclipse Ti microscope (Nikon Instruments Eu-
rope B.V.) using a FITC filter set at the same wave-
lengths as above. In each case observations were 
made from two separate samples of microbubbles and 
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fluorescent droplets prepared independently.  
2.4. Capillary flow model 
A 200 µm diameter cellulose capillary tube (Cu-
prophan RC55 8/200, Membrana GMBH) was sus-
pended in a water bath (23 °C) and perfused with 
magnetic droplets and microbubbles, via a syringe 
into the needle of which the capillary had been in-
serted. Since the tube was both acoustically and opti-
cally transparent, the flowing particles were observed 
using an optical microscope with a water immersion 
objective (LUMPLFLN 40XW Olympus Key Med 
Southend, Essex UK; giving 400x magnification when 
mounted on a World Precision Instruments micro-
scope, H602-240, Sarasota, Fl, USA with a 10x eye 
piece). An N52 grade NdFeB permanent magnet 
(NeoTexx, Berlin, Germany 10 mm x 10 mm x 25 mm) 
with a transverse magnetisation of 0.75 T was held 
approximately 1 mm away from the capillary tube 
wall. Flow rates up to 1 mm/s could be applied. A 
video was recorded of the mixtures flowing in the 
tube using a camera (ThorLabs USB 2.0 digital cam-
era). Multiple perfusions were performed with sam-
ples from different batches of microbubbles and 
magnetic droplets. 
2.5. Ultrasound Flow Phantom 
In addition to further demonstrating the interac-
tion between bubbles and droplets, it was important 
to investigate their echogenicity and also their ability 
to be magnetically retained under flow. The apparatus 
was set up as shown in Figure 2. A latex tube (8 mm 
inner diameter with a wall thickness of 2 mm) was 
suspended in a water bath and connected to a pro-
grammable syringe pump (Al-1000, World Precision 
Instruments, Herts. UK) at one end and an open col-
lection vessel at the other. A section of the tube was 
positioned so that it was parallel to the base of the 
bath with a gap of approximately 3 cm to allow for the 
insertion of a magnet. This took the form of a Halbach 
array consisting of 5 N52 grade NdFeB permanent 
magnets (10 mm x 10 mm x 25 mm, supplied by Ne-
oTexx, Berlin, Germany) with transversal magnetisa-
tions (0.75 T) at angles of 90° from one to the next in 
an aluminium frame. The bubble formulations were 
imaged using an Ultrasonix RP500 ultrasound system 
using an array transducer with a centre frequency of 
2.5 MHz (PA4-2/20). This was positioned above the 
section of tube under which the Halbach array was 
located. The flow rate through the tube was varied 
using the syringe pump and the local velocity profile 
in the imaging plane was determined via particle 
image velocimetry. As soon as an acoustic signal was 
observed from the flowing microbubbles, the Halbach 
array was inserted. Experiments were performed for 
non-magnetic microbubbles, magnetic microbubbles, 
magnetic droplets and finally magnetic droplets 
mixed with microbubbles. Two solutions were pre-
pared independently for each flow experiment and 5 
perfusions performed with each. 
2.6. Flow estimation 
In the experiments, measurements of the axial 
velocity profile in the imaged region of the flow 
phantom were obtained via an ultrasonic particle 
image velocimetry (Echo PIV) method. Echo PIV is a 
non-invasive technique for flow characterisation, 
which overcomes the need for optical access. A series 
of consecutive ultrasound images are recorded. The 
images are then subdivided in smaller domains or 
interrogation areas and the correlation between two 
interrogation areas of consecutive frames is calculat-
ed. An advantage of this technique is its ability to 
measure the whole flow field simultaneously. Image 
pairing is performed through a spatial 
cross-correlation R(s) of the interrogation windows 
W1(x)I1(x) and W2(x)I2(x) as given in equation 1 (22).  
𝑅(𝑠) = ∫𝑊1 (𝑥)𝐼1(𝑥)𝑊2(𝑥 + 𝑠)𝐼2(𝑥 + 𝑠)𝑑𝑥      …(1) 
Where W1 and W2 are functions that determine 
the interrogation windows, and I1 and I2 are the im-
ages. Velocity magnitude is denoted by colour, as 
shown in Figure 3. The volume flow rate is estimated 
from the measured asymmetric axial velocity profiles 
by means of the cos θ method (23). For the cos θ 
method, the flow profile is split into two equal parts at 
the centreline, V1(r) and V2(r). Each part of the profile 
was integrated over half of the surface of the tube. The 
volume flow rate is then approximated from the sum 
of both contributions: 
𝑄 = 𝜋 ∫ 𝑉1𝑅0 (𝑟)𝑟𝑑𝑟 +  𝜋 ∫ 𝑉2𝑅0 (𝑟)𝑟𝑑𝑟          …(2) 
Where R is the inner radius of the tube.  
In order to estimate the shear rate at the wall in 
the region above the magnetic array a Poiseuille flow 
profile was assumed and thus: 
𝛾 = 8𝑉
2𝑟
                      …(3) 
Where γ is the shear rate measured in s-1, V is the 
centreline flow velocity obtained from PIV and r is the 
radius of the tube.  
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Figure 2: Schematic of the ultrasound flow phantom: a latex tube immersed in a water bath with a variable internal flow rate controlled 
by a syringe pump. Microbubble/droplet mixtures were injected into the tube upstream and images obtained using an ultrasound imaging 
probe. A magnetic Halbach array was inserted 2 cm below the latex tube to investigate retention of the microbubbles against the flow. 
 
Figure 3: Ultrasonic particle image velocimetry (Echo PIV) velocity profiles (cm s-1) in the area above the magnetic array in the latex tube 
flow phantom. 
 
3. Results 
3.1. Optical Microscopy 
L-α-phosphatidylcholine (non-magnetic) mi-
crobubbles were prepared as described above and 
examined on a haemocytometer. Microbubbles could 
be discerned at the top of the slide (Figure 4 A). The 
bubbles had a range of sizes (0.6 – 9.6 µm) and an av-
erage concentration of 9.64 x 107 microbubbles/ml 
(Figure 4 F).  
Optical microscope images showed the magnetic 
droplet solution as a mixture of particles of differing 
size (Figure 4 B), which responded by forming chains 
and moving upon application of a magnetic field, as 
shown in Figure 4 C. The magnetic droplets were ob-
served at the bottom of the slide and floating within 
the solution but none were observed at the top of the 
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slide. Non-magnetic droplets showed similar struc-
tures but many of these rose to the top of the slide or 
floated in solution (Figure 5 A). This indicated that the 
magnetic nanoparticles caused a decrease in the 
buoyancy of the droplets as might be expected given 
the relative densities of isoparaffin and magnetite. 
There was also a difference in colour due to the pres-
ence of magnetic nanoparticles.  
 
 
Figure 4: Optical images at 400x magnification of A) phospholipid microbubbles and B) magnetic droplets before and C) after the 
application of a magnetic field showing magnetic droplets in the micrometre scale responding to a magnetic field. D) and E) Phospholipid 
microbubbles combined with magnetic droplets showing D) the top of the slide with large buoyant microbubbles that did not respond to 
a magnetic field and E) particles below the large microbubbles (shown out of focus) lining up upon the application of a magnetic field. Scale 
bar in all images is 50 µm. F) Example of size distribution plot (in this case for non-magnetic microbubbles) obtained from the image 
processing software. 
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Figure 5: Optical microscope images (400x magnification) of: A) Non-magnetic droplets imaged at the top of the haemocytometer and 
B) non-magnetic droplets mixed with microbubbles in the same focal plane. Two separate populations of microbubbles and droplets on 
the micrometre scale can be observed. Scale bar in all images is 50 µm. 
 
The magnetic droplet/microbubble mixture was 
placed directly onto the haemocytometer. Some rela-
tively large microbubbles could be seen at the top of 
the slide which did not respond to a magnetic field 
(Figure 4 D). Throughout the solution however there 
were spherical particles which were magnetically re-
sponsive. The structure seemed to be similar to the 
solution of magnetic droplets and no interaction be-
tween the magnetic droplets and the microbubbles 
could be discerned. Figure 4 E shows the magnetic 
droplets responding to a magnetic field with mi-
crobubbles out of focus above the droplets. Similarly, 
no interaction could be discerned between 
non-magnetic droplets and microbubbles as shown in 
Figure 5 B. 
3.2. Fluorescence Microscopy 
Fluorescent magnetic droplets were examined in 
water by fluorescence microscopy. A mixture of vesi-
cles of differing size were observed by phase contrast 
(Figure 6 A) and seen to fluoresce upon use of the 
FITC filter set (Figure 6 B). Non-magnetic phospho-
lipid microbubbles were examined to confirm that no 
fluorescence was observed. Upon mixing the mi-
crobubbles with the fluorescent magnetic droplets, 
however the microbubbles were now observed to 
fluoresce as shown in the phase contrast (Figure 6 C) 
and fluorescence (Figure 6 D) images below. The mi-
crobubbles continued to fluoresce after centrifugation 
(10,000 RPM for 15 min) indicating a strong interac-
tion between the microbubbles and the droplets. This 
finding was confirmed with 3 separate samples. 
Fluorescent isoparaffin droplets, without mag-
netic nanoparticles, were also mixed with phospho-
lipid microbubbles. The microbubbles were observed 
by phase contrast, as shown in Figure 7 A, and the 
microbubbles are also seen to fluoresce as shown in 
Figure 7 B. The results are similar to those shown in 
Figure 6 with fluorescent magnetic droplets indicating 
that the magnetic nanoparticles were not essential to 
the interaction. Again this finding was confirmed 
with 3 independently prepared samples. 
3.3. Capillary flow 
The magnetic droplet/microbubble mixture was 
then injected into the optical flow phantom in order to 
observe whether the particles could be retained by a 
magnetic field (Figure 8 A). Upon insertion of the 
magnet into the water bath the majority of objects 
were observed forming chains and translating to-
wards the magnet (Figure 8 B). Retention of mi-
crobubbles was observed at centre line velocities up to 
1 mm/s, which was the maximum velocity of the 
system corresponding to a shear rate of 20 s-1. This 
observation was consistent in all samples tested 
(minimum of at least 3). 
3.4. Ultrasound flow phantom 
Ultrasound imaging in a larger scale flow phan-
tom was carried out in order to examine the echo-
genicity of the particles and whether or not retention 
was possible in a larger vessel at higher flow rates. 
First, L-α-phosphatidylcholine magnetic microbub-
bles were injected. As soon as the magnetic mi-
crobubbles were observed on the ultrasound scanner 
(Figure 9 A), the Halbach array was inserted and re-
tention of magnetic microbubbles was observed as 
shown in Figure 9 B and C. Upon removal of the 
Halbach array, the magnetic microbubbles were re-
moved by flow in the tube (Figure 9 D). Retention of 
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magnetic microbubbles was observed for flow rates of 
up to ~6 cm/s (Figure 3). This corresponds to shear 
rates of between 20 and 60 s-1. For each flow rate, re-
tention was confirmed with a minimum of 3 injections 
of magnetic bubbles. 
L-α-phosphatidylcholine microbubbles alone 
were injected into the flow phantom and could be 
easily observed on the scanner (Figure 10 A) but, as 
would be expected, no retention was observed upon 
insertion of the Halbach array. Magnetic droplets 
were injected into the flow phantom and, also as ex-
pected, no acoustic signal was detected (Figure 10 B) 
and consequently again upon insertion of the Halbach 
array no effect was observed. Finally, the magnetic 
droplet/microbubble mixture was injected into the 
flow phantom. A clear signal from particles in the 
tube could be seen on the scanner as shown in Figure 
10 and upon insertion of the Halbach array retention 
was observed at flow rates up ~6 cm/s as shown in 
Figure 10 D. This was observed consistently for three 
injections from two different mixtures. No fluorescent 
formulations were used in the flow phantom experi-
ments. 
 
Figure 6: Fluorescent magnetic droplet mixture under optical microscopy shown in phase contrast in A) and fluorescence image in B) at 
100x magnification (scale bar in A is 25 µm for images A and B). C) Phase contrast image of a microbubble (400x magnification) in a 
mixture of fluorescent magnetic droplets and D) a fluorescence image of the same microbubble now fluorescing indicating the mi-
crobubble is interacting with fluorescent magnetic droplets. 
 
Figure 7: Microbubbles mixed with fluorescent isoparaffin droplets fluorescing indicating that the microbubbles are interacting with the 
oil based as well as the magnetic droplets. Scale bars are shown in the diagram (100 µm). 
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Figure 8: Microbubbles mixed with magnetic droplets in a 200 µm capillary tube before A) and B) after the application of a magnetic field. 
 
Figure 9: Ultrasound images from the flow phantom study: A) magnetic microbubbles flowing through an 8mm inner diameter latex tube, 
B) a magnetic array is brought underneath and magnetic microbubbles are retained at the lower surface of the tube and C) the number of 
bubbles retained increases over time. When the magnetic array is removed (D) the microbubbles are removed by the flow. 
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Figure 10: Magnetic droplets and microbubbles being retained under flow in vitro: A) non-magnetic microbubbles showing no retention 
upon application of a magnetic field (distributed throughout the tube), B) magnetic droplets showing no ultrasound signal when flowing 
through a latex tube (centre of the tube appears dark), C) a mixture of magnetic droplets and microbubbles flowing through the tube 
(again tube is filled with echogenic material) and D) being retained by a magnetic field. 
 
4. Discussion 
The optical microscopy images (Figure 4) appear 
to indicate that there was no interaction between the 
magnetic droplets and the microbubbles upon mixing. 
On this basis it might be concluded that the increased 
levels of transfection observed in the previous gene 
delivery experiments (19) were due to an interaction 
between the droplets and the cells, which potentiated 
the subsequent effect of the microbubble oscillations. 
The fluorescence images, however, suggest otherwise 
(Figure 6). Upon mixing with the droplets, the initially 
non-fluorescent bubbles were seen to fluoresce, indi-
cating that the magnetic droplets were coating or co-
alescing with the microbubble surface. The fact that 
the bubbles remained fluorescent after centrifuging 
suggests that the interaction produced strong binding. 
To investigate whether the magnetic nanoparticles 
were integral to the interaction, isoparaffin-only flu-
orescent droplets were synthesised and the process 
was repeated. The microbubbles were still observed to 
fluoresce as shown in Figure 7. 
It was evident from its colour, even under optical 
microscopy, that the magnetic droplet suspension 
contained objects on the nano- as well as the micro- 
scale which cannot be resolved optically. This is sup-
ported by results in a recent publication regarding 
magnetoliposomes which showed that oleic acid 
coated iron oxide nanoparticles aggregated when 
mixed with phospholipid in aqueous solution (24). 
These magnetic droplets most likely interact with the 
phospholipid microbubbles. Evidence for this is that 
when the microbubbles fluoresce, microscale vesicles 
are still fluorescing nearby and optical microscope 
images appear to show no interaction between the 
microscale droplets and the microbubbles. As the mi-
crobubbles now fluoresce it is reasonable to assume 
that interaction must come from nanoscale droplets.  
The interaction appeared to be strong enough to 
withstand centrifugation and resist hydrodynamic 
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forces within an aqueous suspension. The influence of 
different species in the suspending medium on the 
interaction was not investigated but the microbubble 
and the magnetic droplets are both coated in phos-
pholipids with polar head groups oriented towards 
the water and as such should be stable. To the au-
thors’ knowledge, no studies or models have been 
reported which examine the interaction between 
bubbles and droplets. Studies have been performed 
however on lecithin vesicles where large vesicles 
grow at the expense of smaller ones due to size dis-
proportionation or Ostwald ripening (25) and one 
possibility is that it is a similar mechanism by which 
droplets and microbubbles form magnetic microbub-
bles. Such a process is determined by energetic stabil-
ity, small droplets are kinetically stable whereas large 
droplets are thermodynamically stable; due to the 
surface to volume ratio (26).  
In order to obtain an approximate comparison of 
the relative surface energies of the microbubble and 
the magnetic droplet, the Laplace pressure must be 
calculated using: 
𝑃𝜎 = 2𝜎𝑅                            …(4) 
Where σ is the interfacial tension and R is the radius of 
the bubble or droplet. The surface energy can then be 
found as: 
𝐹 = 𝜎 ∫𝑑𝐴 −  𝑃𝜎 ∫𝑑𝑉                …(5) 
Where A is the surface area and V is the volume. The 
interfacial tension for an air and water interface is 
72.75 mN/m at room temperature, and for water and 
isoparaffin is 48 mN/m (27). The microbubbles had a 
modal diameter, from Figure 4, of 2.5 µm. The drop-
lets coating the microbubbles must be on the na-
noscale and a variable size between 20 and 200 nm 
was assumed. With these figures a surface energy of – 
2.38 x 10-12 Nm is obtained for a 2.5 µm air microbub-
ble in water which is lower than -1.01 x 10-16 Nm for a 
20 nm oil droplet. A 200 nm droplet has a surface en-
ergy of -1.01 x 10-14 Nm which is still lower than for a 
microbubble. A 2 µm droplet has a surface energy of 
-1.01 x 10-12 Nm which is of the same order of magni-
tude as the microbubble. This indicates that a na-
noscale droplet would be likely to interact with the 
microbubble whereas a micrometre scale droplet 
would not.  
These calculations do not take into account the 
lipid coating of the droplet or the microbubble. The 
presence of a lipid monolayer would lower the inter-
facial tension in both cases. However, the system 
would still be expected to adopt a more energetically 
favourable state and lipids are known to mediate fu-
sion between vesicles and membranes (28). The in-
fluence of additional membrane components such as 
polyethylene glycol (PEG), which are present in 
commercially available microbubbles to aid biocom-
patibility, might inhibit interaction between mi-
crobubbles and droplets but the aim of this study was 
to investigate the microbubble compositions used in 
[19] which did not contain PEG. 
4.1. Flow phantom results  
The interaction between the magnetic droplets 
and the microbubbles to form magnetic microbubbles 
was further reinforced by the flow phantom studies. 
Upon optical observation of the magnetic drop-
let/microbubble mixture in a 200 µm capillary tube, 
objects similar to magnetic microbubbles were ob-
served and responded upon application of a magnetic 
field as shown in Figure 8. The whole population re-
sponded in the absence of flow and a subpopulation 
was retained against shear rates of approximately 20 
s-1. It was, however, difficult to distinguish optically 
between magnetic microbubbles and large magnetic 
droplets; but under ultrasound imaging it was shown 
that particles that were both magnetically and acous-
tically responsive could be successfully retained by a 
magnetic field against shear rates of up to ~60s-1 (10).  
These results also indicate that magnetic mi-
crobubbles can be retained under physiologically 
relevant flow conditions. Blood flow rates and wall 
shear stresses vary considerably throughout the body. 
For example, the mean shear rate can vary from 40 s-1 
in the Venae cavae to 580 s-1 in the capillaries (29) (30). 
Evidence of successful retention in vivo has already 
been shown in a mouse model (31) but further work is 
required to assess the feasibility of retention over a 
wider range of shear rates and of generating the re-
quired magnetic field strengths and gradients at 
larger tissue depths. 
5. Summary and Conclusions 
The aim of this study was to investigate the 
mechanisms underlying the results of a previous in-
vestigation in which it was shown that a mixture of 
magnetic liquid droplets and non-magnetic mi-
crobubbles was more effective for gene delivery than 
a suspension of magnetic microbubbles. Two possible 
mechanisms were proposed: that the magnetic drop-
lets sensitised the cells to sonoporation or that some 
form of association between the droplets and the mi-
crobubbles occurred producing particles that were 
both magnetically and acoustically responsive.  
The observations under optical microscopy in 
this study were in agreement with those from the 
previous work and seemed to indicate that no inter-
action took place between the droplets and particles. 
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Optical images of the mixed suspension in a capillary 
tube in the presence of a magnetic field however in-
dicated particles that were buoyant (and therefore not 
magnetic liquid droplets) and did respond upon ap-
plication of a magnetic field. Fluorescence microscopy 
confirmed that initially non-fluorescent bubbles be-
came coated with fluorescent droplets and that the 
interaction was sufficiently strong to resist centrifu-
gation. Further examination indicated that the coating 
was effected by nanoscale liquid droplets and this was 
why the interaction was not visible under optical mi-
croscopy. Surface energy calculations also showed 
that the magnetic droplets had a lower surface energy 
than the lipid-coated microbubbles; consequently, 
adsorption of the droplets to the microbubbles was 
energetically favourable. Thus it may be reasonably 
concluded that the results obtained in the previous 
gene delivery study may be attributed to this interac-
tion. The reason for the higher transfection rates is 
possibly due to a higher concentration of magnetically 
and acoustically responsive particles being formed 
than that present in the magnetic microbubble sus-
pension. Alternatively the response to the ultrasound 
and/or magnetic field may have been different and 
this will require further investigation.  
Both the magnetic microbubbles and the parti-
cles formed from the mixed suspension were echo-
genic and readily detected under ultrasound imaging. 
They could also be retained by a magnetic field at 
centre line velocities of 6 cm s-1 and shear rates of ~60 
s -1. These results are promising with respect to the use 
of magnetic microbubbles as therapeutic delivery ve-
hicles in vivo. These successful preliminary tests need 
to be fully explored, however. In particular, experi-
ments are required to examine the factors that affect 
retention: a wider range of flow rates and vessel sizes; 
the magnitude as well as the gradient of the magnetic 
field; the distance between the magnet and the vessel 
(i.e. tissue depth); the liquid density, viscosity and 
pulsatility. Further investigation of the particle inter-
nal structure and their performance in therapeutic 
delivery will also be required. 
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